Targeting EGFR signalling pathway in triple negative breast cancer

<p>Epidermal growth factor receptor (EGFR) is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic response...

Descripció completa

Dades bibliogràfiques
Autor principal: Albukhari, A
Altres autors: Ahmed, A
Format: Thesis
Idioma:English
Publicat: 2014
Matèries: